EP3386592A4 - Method and system for characterization of clostridium difficile-associated conditions - Google Patents
Method and system for characterization of clostridium difficile-associated conditions Download PDFInfo
- Publication number
- EP3386592A4 EP3386592A4 EP16873997.7A EP16873997A EP3386592A4 EP 3386592 A4 EP3386592 A4 EP 3386592A4 EP 16873997 A EP16873997 A EP 16873997A EP 3386592 A4 EP3386592 A4 EP 3386592A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- characterization
- clostridium difficile
- associated conditions
- conditions
- difficile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/10—Ontologies; Annotations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/30—Data warehousing; Computing architectures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Epidemiology (AREA)
- Bioethics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Evolutionary Biology (AREA)
- Theoretical Computer Science (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Software Systems (AREA)
- Evolutionary Computation (AREA)
- Primary Health Care (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562265077P | 2015-12-09 | 2015-12-09 | |
US15/097,862 US9710606B2 (en) | 2014-10-21 | 2016-04-13 | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues |
PCT/US2016/065993 WO2017100688A1 (en) | 2015-12-09 | 2016-12-09 | Method and system for characterization of clostridium difficile-associated conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3386592A1 EP3386592A1 (en) | 2018-10-17 |
EP3386592A4 true EP3386592A4 (en) | 2019-05-22 |
Family
ID=59013380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16873997.7A Pending EP3386592A4 (en) | 2015-12-09 | 2016-12-09 | Method and system for characterization of clostridium difficile-associated conditions |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3386592A4 (en) |
CN (1) | CN108472506B (en) |
AU (1) | AU2016366656A1 (en) |
CA (1) | CA3007503A1 (en) |
WO (1) | WO2017100688A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190211377A1 (en) * | 2016-12-22 | 2019-07-11 | Roche Molecular Systems, Inc. | Cobra probes to detect a marker for epidemic ribotypes of clostridium difficile |
WO2019075426A1 (en) * | 2017-10-13 | 2019-04-18 | Rebiotix, Inc. | Microbiome health index |
CN108486228B (en) * | 2018-05-25 | 2021-07-09 | 上海交通大学医学院附属上海儿童医学中心 | Fluorescent quantitative PCR detection kit for pre-judging sepsis infection condition and method thereof |
WO2020012467A2 (en) * | 2018-07-08 | 2020-01-16 | Yeda Research And Development Co. Ltd. | Person-specific assessment of probiotics responsiveness |
CA3112004A1 (en) * | 2018-09-06 | 2020-03-12 | Viome, Inc. | Systems and methods for microbiome analysis |
EP3864639A4 (en) | 2018-10-08 | 2022-07-06 | Viome Life Sciences, Inc. | Methods for and compositions for determining food item recommendations |
CN112481395A (en) * | 2019-09-12 | 2021-03-12 | 深圳华大生命科学研究院 | Clostridium difficile drug-resistant/low-sensitive clade SNP marker, strain type identification method and application |
CN113555059B (en) * | 2021-06-25 | 2024-02-02 | 中国科学院南京地理与湖泊研究所 | Method for quantifying coupling relation between organic carbon and microorganism under environmental change |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015013214A2 (en) * | 2013-07-21 | 2015-01-29 | Whole Biome, Inc. | Methods and systems for microbiome characterization, monitoring and treatment |
US20150211055A1 (en) * | 2014-01-25 | 2015-07-30 | uBiome, Inc. | Method and system for microbiome analysis |
WO2015170979A1 (en) * | 2014-05-06 | 2015-11-12 | Is-Diagnostics Ltd. | Microbial population analysis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2102350A4 (en) * | 2006-12-18 | 2012-08-08 | Univ St Louis | The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder |
US20130045874A1 (en) * | 2010-03-01 | 2013-02-21 | Institut National De La Recherche Agronomique | Method of Diagnostic of Inflammatory Bowel Diseases |
US10920283B2 (en) * | 2013-11-01 | 2021-02-16 | Washington University | Methods to establish and restore normal gut microbiota function of subject in need thereof |
-
2016
- 2016-12-09 EP EP16873997.7A patent/EP3386592A4/en active Pending
- 2016-12-09 WO PCT/US2016/065993 patent/WO2017100688A1/en active Application Filing
- 2016-12-09 AU AU2016366656A patent/AU2016366656A1/en not_active Abandoned
- 2016-12-09 CA CA3007503A patent/CA3007503A1/en active Pending
- 2016-12-09 CN CN201680077988.9A patent/CN108472506B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015013214A2 (en) * | 2013-07-21 | 2015-01-29 | Whole Biome, Inc. | Methods and systems for microbiome characterization, monitoring and treatment |
US20150211055A1 (en) * | 2014-01-25 | 2015-07-30 | uBiome, Inc. | Method and system for microbiome analysis |
WO2015170979A1 (en) * | 2014-05-06 | 2015-11-12 | Is-Diagnostics Ltd. | Microbial population analysis |
Non-Patent Citations (2)
Title |
---|
See also references of WO2017100688A1 * |
XOCHITL C. MORGAN ET AL: "Biodiversity and functional genomics in the human microbiome", TRENDS IN GENETICS., vol. 29, no. 1, 1 January 2013 (2013-01-01), NL, pages 51 - 58, XP055470567, ISSN: 0168-9525, DOI: 10.1016/j.tig.2012.09.005 * |
Also Published As
Publication number | Publication date |
---|---|
CN108472506A (en) | 2018-08-31 |
EP3386592A1 (en) | 2018-10-17 |
AU2016366656A1 (en) | 2018-06-28 |
CA3007503A1 (en) | 2017-06-15 |
WO2017100688A1 (en) | 2017-06-15 |
CN108472506B (en) | 2022-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3272087A4 (en) | System and method of waveform design for operation bandwidth extension | |
EP3238466A4 (en) | Method and system for audio sharing | |
EP3253282A4 (en) | Method and system for interacting with an environment | |
EP3215938A4 (en) | System and method for fast starting an application | |
EP3238133A4 (en) | System and method for improved display | |
EP3117363A4 (en) | Method and system for detecting bot behavior | |
EP3212108A4 (en) | System and method for instrument disturbance compensation | |
EP3386592A4 (en) | Method and system for characterization of clostridium difficile-associated conditions | |
EP3186151A4 (en) | Docking system and method for satellites | |
EP3129885A4 (en) | Software test automation system and method | |
EP3108030A4 (en) | System and method for bi-facial processing of substrates | |
EP3178011A4 (en) | Method and system for facilitating terminal identifiers | |
EP3123645A4 (en) | Method and system for performing measurements based on synchronization signal properties | |
EP3189324A4 (en) | Method and system for microscopy | |
EP3396917A4 (en) | Method and apparatus for isolating environment | |
EP3105965A4 (en) | System and method for connection rehoming | |
EP3217967A4 (en) | System and method for preventing alopecia | |
EP3283084A4 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions | |
EP3402912A4 (en) | Hydrogen system and method of operation | |
EP3318972A4 (en) | System for providing application list and method therefor | |
EP3331976A4 (en) | System and method for extracting essential oils | |
EP3281079A4 (en) | System and method for estimating cognitive traits | |
EP3256937A4 (en) | Responsive course design system and method | |
EP3220346A4 (en) | Method for sharing content and content sharing system | |
EP3426794A4 (en) | Method and system for characterizing mouth-associated conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180607 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20190423 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G16H 50/50 20180101ALI20190415BHEP Ipc: G16H 10/40 20180101ALI20190415BHEP Ipc: G16B 50/00 20190101ALI20190415BHEP Ipc: A61P 31/04 20060101AFI20190415BHEP Ipc: C12Q 1/689 20180101ALI20190415BHEP Ipc: C12Q 1/6883 20180101ALI20190415BHEP Ipc: G16B 40/00 20190101ALI20190415BHEP Ipc: A61K 38/08 20190101ALI20190415BHEP Ipc: G16H 50/20 20180101ALI20190415BHEP Ipc: A61P 43/00 20060101ALI20190415BHEP |
|
19U | Interruption of proceedings before grant |
Effective date: 20191011 |
|
19W | Proceedings resumed before grant after interruption of proceedings |
Effective date: 20201201 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PSOMAGEN, INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20210318 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |